Skip to content

Pain Relief Investigation of NeuroModulation Therapy in Adult Humans

PRIMA Study: Pain Relief Investigation of NeuroModulation Therapy in an Adult Population: A Double Blind, Randomized, Multicenter, Placebo Controlled Trial.

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00253032
Enrollment
Unknown
Registered
2005-11-15
Start date
Unknown
Completion date
Unknown
Last updated
2006-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Musculoskeletal Pain

Brief summary

The study is being performed to determine the efficacy and safety of Fralex Neuromodulation Therapy (F-NMT), delivered by the Fralex PRIMA device, in reducing chronic musculoskeletal pain.

Interventions

DEVICEPRIMA

Sponsors

PharmaNet
CollaboratorINDUSTRY
Fralex Therapeutics
Lead SponsorINDUSTRY

Eligibility

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026